Breast Cancer

FDA clears new method for managing non-cancerous breast lumps

Published in Medical Letter on the CDC and FDA, December 28th, 2003

Ethicon Endo-Surgery has announced that millions of women who have non-cancerous breast lumps can now receive care in a doctor's office with a minimally invasive device rather than having the lump removed by invasive surgery in an operating room.

Ethicon received clearance from the U.S. Food and Drug Administration (FDA) to expand the use of its Mammotome Breast Biopsy System so doctors can now use it for management of fibroadenomas (palpable non-cancerous breast lumps), a condition common among young women in their late teens, twenties and thirties. The Mammotome System has already been used for more than 1.7 million breast biopsies since 1995.

A...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2003-12-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry